015 CAR-T Cell Therapy: The Age of Living Cancer Drugs

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/6a/e7/b3/6ae7b3f9-85ab-7750-63ab-8a331f757153/mza_6665452136322097604.jpg/600x600bb.jpg

For Whom the Cell Tolls: Cancer Biology

Prof. Keenan Hartert

27 episodes

4 days ago

Welcome to For Whom the Cell Tolls! This cast explores the fascinating stories of Biology that I've encountered in my journey as a Biology Professor and lymphoma scientist at Minnesota State University and my previous experience at Mayo Clinic. Major themes to be explored include cancer, tumorigenesis, new therapy mechanisms, immunology, life/death, disease ecology, microbiology, and evolution, among others. I try to integrate philosophy, culture, and the arts alongside emerging Biology findings to share the stories of life that I have always loved. Enjoy! https://profkeenanhartert.weebly.com

Science

RSS

All content for For Whom the Cell Tolls: Cancer Biology is the property of Prof. Keenan Hartert and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/1137250/1137250-1540585320866-fd750305d3e21.jpg

015 CAR-T Cell Therapy: The Age of Living Cancer Drugs

For Whom the Cell Tolls: Cancer Biology

32 minutes 14 seconds

6 years ago

015 CAR-T Cell Therapy: The Age of Living Cancer Drugs

Chimeric Antigen Receptor T-cells (CAR-T) represent one of the most profound and exciting advances in modern medicine and science. Many lymphoma patients fail therapy after therapy with little recourse. CAR-T aimed to stop that. Taking immune T-cells from the patient, engineering them to target cancer cells, and re-releasing them into the patient would’ve sounded crazy 20 years ago. Thanks to modern technology, science, and clinical practice we’ve created something powerful. The CAR-T enter patients and attack the tumor, but a massive immune reaction can induce massive side effects. This episode explores some of the exciting news, future possibilities, and ethical challenges of CAR-T use for lymphoma treatments. I hope you enjoy!